KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Intangibles (2016 - 2025)

Historic Intangibles for Emergent BioSolutions (EBS) over the last 13 years, with Q3 2025 value amounting to $452.7 million.

  • Emergent BioSolutions' Intangibles fell 1257.24% to $452.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $452.7 million, marking a year-over-year decrease of 1257.24%. This contributed to the annual value of $501.5 million for FY2024, which is 1148.96% down from last year.
  • Emergent BioSolutions' Intangibles amounted to $452.7 million in Q3 2025, which was down 1257.24% from $469.0 million recorded in Q2 2025.
  • In the past 5 years, Emergent BioSolutions' Intangibles registered a high of $728.8 million during Q4 2022, and its lowest value of $452.7 million during Q3 2025.
  • In the last 5 years, Emergent BioSolutions' Intangibles had a median value of $582.8 million in 2023 and averaged $578.3 million.
  • In the last 5 years, Emergent BioSolutions' Intangibles surged by 2054.25% in 2022 and then crashed by 2225.58% in 2023.
  • Emergent BioSolutions' Intangibles (Quarter) stood at $604.6 million in 2021, then increased by 20.54% to $728.8 million in 2022, then decreased by 22.26% to $566.6 million in 2023, then dropped by 11.49% to $501.5 million in 2024, then dropped by 9.73% to $452.7 million in 2025.
  • Its last three reported values are $452.7 million in Q3 2025, $469.0 million for Q2 2025, and $485.2 million during Q1 2025.